tissue
-
Biologics
AlloSource Medical Director Dr. Hannis Thompson Recognized For His Exceptional Contributions In Tissue Banking At AATB Annual Meeting
CENTENNIAL, Colo., Oct. 3, 2024 /PRNewswire/ — AlloSource today announced Medical Director, Dr. Hannis Thompson, has received the George W. Hyatt Memorial Award, celebrating his exceptional…
Read More » -
Biologics
DiscGenics Announces Research Collaboration with the U.S. Department of Veterans Affairs for Tissue-Engineered Discs with Discogenic Cells
Feasibility Project Awarded VA Technology Transfer Program BRAVE Funding SALT LAKE CITY, Oct. 18, 2023 /PRNewswire/ — DiscGenics, Inc., a privately held, late-stage…
Read More » -
Sports Medicine
First-of-Its-Kind Selective Tissue Removal Patent Grant
BOSTON , June 8, 2022 /PRNewswire/ — Today, HydroCision Inc. announced that the U.S. Patent and Trademark Office has issued a new patent, No.…
Read More » -
Recon
HSS Study Finds That MRI Identifies Adverse Tissue Reactions are Common in Asymptomatic Individuals After Hip Resurfacing Arthroplasty
NEW YORK, July 8, 2021 /PRNewswire/ — Magnetic resonance imaging (MRI) identified adverse local tissue reactions in patients who received hip replacements, even…
Read More » -
Biologics
NASA Highlights Winners of Challenge to Engineer Human Tissue
WASHINGTON, June 7, 2021 /PRNewswire/ — NASA will announce the first- and second-place winners of the Vascular Tissue Challenge, a prize competition to grow…
Read More » -
Biologics
Nanostructured rubber-like material with optimal properties could replace human tissue
March 16, 2020 / Chalmers University of Technology Researchers from Chalmers University of Technology, Sweden, have created a new, rubber-like…
Read More » -
Biologics
Vancouver biotech firm’s ‘3D bio-printing’ to create human tissue for transplant needs
January 28, 2017 – from Chuck Chiang Patients who tear, rupture or otherwise damage cartilage or other bodily tissue may one…
Read More » -
Biologics
Tissue Regenix Group plc – DermaPure secures GPO agreement with Premier, Inc.
Leeds, 06 December 2016 – Tissue Regenix Group (AIM:TRX) (“Tissue Regenix” or “The Group”) the regenerative medical devices company today…
Read More » -
Spine
Medovex Corporation Announces Successful Largest Living Tissue Population Test to Date
ATLANTA, GA–(Marketwired – Nov 2, 2016) – Medovex Corp. (NASDAQ: MDVX), a developer of medical technology products, today announced that…
Read More » -
Biologics
Tissue Regenix Group plc: DermaPure® – Two Peer Reviewed Clinical Papers Published
September 15, 2016 LEEDS, England–(BUSINESS WIRE)– Tissue Regenix Group (TRX.L) (“Tissue Regenix” or “The Group”) will publish for the first…
Read More » -
Financial
Progenerative Medical Obtains Exclusive Rights to Tissue Regeneration Technology
SAN ANTONIO, Sept. 14, 2016 /PRNewswire Progenerative Medical, Inc. (PGM), a clinical-ready medical device company announced today they have entered into a…
Read More »